Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smulders, R. H.P.H.
Right arrow Articles by de Jong, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smulders, R. H.P.H.
Right arrow Articles by de Jong, W. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 46, Issue of November 15, 1996 pp. 29060-29066
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Immobilization of the C-terminal Extension of Bovine alpha A-Crystallin Reduces Chaperone-like Activity*

(Received for publication, June 13, 1996, and in revised form, September 4, 1996)

Ronald H. P. H. Smulders Dagger , John A. Carver §, Robyn A. Lindner §, Martinus A. M. van Boekel Dagger , Hans Bloemendal Dagger and Wilfried W. de Jong Dagger

From the Dagger  Department of Biochemistry, University of Nijmegen, 6500 HB Nijmegen, The Netherlands and the § Department of Chemistry, University of Wollongong, Northfields Avenue, Wollongong, New South Wales 2522, Australia

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

alpha -Crystallins occur as multimeric complexes, which are able to suppress precipitation of unfolding proteins. Although the mechanism of this chaperone-like activity is unknown, the affinity of alpha -crystallin for aggregation-prone proteins is probably based on hydrophobic interactions. alpha -Crystallins expose a considerable hydrophobic surface to solution, but nevertheless they are very stable and highly soluble. An explanation for this paradox may be that alpha -crystallin subunits have a polar and unstructured C-terminal extension that functions as a sort of solubilizer. In this paper we have described five alpha A-crystallins in which charged and hydrophobic residues were inserted in the C-terminal extension. Introduction of lysine, arginine, and aspartate does not substantially influence chaperone-like activity. In contrast, introduction of a hydrophobic tryptophan greatly diminishes functional activity. CD experiments indicate that this mutant has a normal secondary structure and fluorescence measurements show that the inserted tryptophan is located in a polar environment. However, NMR spectroscopy clearly demonstrates that the presence of the tryptophan residue dramatically reduces the flexibility of the C-terminal extension. Furthermore, the introduction of this tryptophan results in a considerably decreased thermostability of the protein. We conclude that changing the polarity of the C-terminal extension of alpha A-crystallin by insertion of a highly hydrophobic residue can seriously disturb structural and functional integrity.


INTRODUCTION

The composition of the vertebrate eye lens is dominated by a group of structural proteins known as crystallins. The largest of these, alpha -crystallin, is a dynamic multimeric complex composed of two types of homologous subunits, alpha A- and alpha B-crystallin (1). A few years ago, it was discovered that these subunits are also constitutively expressed in various non-lenticular tissues, suggesting that their function is more than merely structural (2, 3, 4, 5). In addition, increased expression of alpha B-crystallin has been observed in a variety of neurodegenerative disorders such as multiple sclerosis (6), Alexander's disease (7, 8), and Alzheimer's disease (9, 10). Although the physiological significance of this extralenticular expression is unknown, it certainly relates to the fact that alpha -crystallins belong to the family of small heat shock proteins (hsp)1 (11, 12). Among the shared features of alpha -crystallins and other small hsp are the conferring of thermotolerance (13, 14), interaction with actin (15, 16), phosphorylation (17, 18), and intracellular relocalization upon stress (19, 20). Furthermore, in vitro experiments have shown that alpha A- and alpha B-crystallin as well as hsp25 can act as molecular chaperones by suppressing aggregation of denaturing proteins (21, 22, 23). Unfortunately, the mechanism of this functional activity is unclear because the three-dimensional structure of alpha -crystallin is unknown.

Native alpha -crystallins occur as polydisperse particles with an average molecular mass of about 800 kDa. Understanding the multimeric arrangement of these subunits is essential for defining structure-function relationships. Recently, solvent-accessible cylindrical (24) and open micellar arrangements (25) were proposed as alternatives for previous models such as the solid three-layered (26, 27) and rhombododecahedric structures (28). However, none of these quaternary structure models is based on substantial experimental evidence. The subunits mainly comprise beta -sheets (29, 30), and several biophysical studies endorse a tertiary structure composed of two compact domains and an unstructured C-terminal region (31, 32, 33, 34). Indeed, as shown by NMR spectroscopy, alpha -crystallin (35) and hsp25 (36) have unstructured, flexible, and solvent-exposed C-terminal extensions. Finally, like other chaperones, such as GroEL, alpha -crystallin seems to suppress aggregation by providing appropriately placed hydrophobic surfaces for denaturing protein substrates (37, 38, 39).

The purpose of the present work is to study the influence of the C-terminal extension on chaperone-like activity. It is known that the extensions are very sensitive to various kinds of enzymatic and non-enzymatic modifications (for a review see Ref. 1). For example, enzymatic truncation of the C terminus with calpain II or trypsin results in a decreased chaperone-like activity (40, 41). Although sequence alignment shows that the extensions in alpha -crystallins and small hsp are quite variable, their composition is remarkably dominated by polar and charged amino acid residues (12, 42). This suggests that the extensions may have a role in solubilizing the hydrophobic complexes formed between alpha -crystallin particles and denatured proteins. To explore such a hypothesis, we have studied the structure and functional behavior of a number of alpha A-crystallin mutants in which charged and hydrophobic residues were inserted into the C-terminal extension.


EXPERIMENTAL PROCEDURES

Materials

Ampicillin, chloramphenicol, isopropyl-1-thio-beta -D-galactopyranoside, bovine pancreas insulin, dithiothreitol, and protease inhibitors were obtained from Sigma. 8-Anilino-1-naphthalenesulfonic acid was purchased from Molecular Probes. The Escherichia coli strain used for expression experiments was B BL21(DE3)pLysS (43).

Expression and Purification

cDNAs encoding wild-type and mutants of bovine alpha A-crystallin were transformed in the host E. coli B BL21(DE3)pLysS. Induction, cell lysis, and fractionation were essentially performed as described by Merck et al. (33). Proteins were purified via anion exchange chromatography with a Fast Flow DEAE-Sepharose column (Pharmacia Biotech Inc.) and a DE52 column (Whatman) (44). For structural and functional studies, wild-type and mutants were refolded in urea as described previously (44).

Chaperone Assay

Chaperone-like activity was determined essentially as described by Farahbakhsh et al. (45). Briefly, various amounts of wild-type and mutant alpha A-crystallins (61, 122, or 245 µg) were preincubated with 245 µg of bovine pancreas insulin for 3 min at 40 °C. Denaturation of insulin was initiated by addition of 20 µl of 1 M dithiothreitol and scattering was monitored for 15 min at 360 nm using a Perkin-Elmer Lambda 2 UV-visible spectrophotometer equipped with a thermostated circulating water bath and a thermocouple to register the sample temperature. Total volume was 1.0 ml, and all solutions were in phosphate buffer (0.1 M Na2SO4, 20 mM NaPi, pH 6.9).

NMR Spectroscopy

1H NMR spectra were recorded at 400 and 600 MHz on Varian-Unity 400 and Bruker DMX-600 spectrometers, respectively. Proteins were at a concentration of 28 mg/ml. Measurements were performed in phosphate buffer (0.1 M Na2SO4, 20 mM NaPi, 99.9% D2O), and, depending on the protein sample, the pH was varied from 6.9 to 7.5 to optimize solubility. All two-dimensional spectra were acquired with 512 t1 increments over 2048 t2 points using the time-proportional phase incrementation method to obtain pure-phase spectra (46) with 32 or 64 scans/t1 increment. Clean-TOCSY spectra (47) using a MLEV-17 spin lock (48) were acquired with various mixing times in the range from 30 to 66 ms. The NOESY spectrum (49) of the ALDKG mutant had a mixing time of 120 ms. For spectra acquired in D2O, the residual solvent resonance was removed by presaturation for 1.5 s with a low powered, continuous pulse using the transmitter. For the two-dimensional experiments in H2O, solvent suppression was accomplished by application of the WATERGATE scheme (50) for the read pulse. In this scheme, solvent suppression is achieved by a combination of gradient-tailored excitation and pulsed-field gradients. Spectra were processed with either Varian or Bruker software or, in the main, with FELIX 95.0 software (Biosym). For processing, the data were zero filled to a matrix size of 2048 × 2048 data points prior to multiplication in both dimensions with shifted sine-bell or Gaussian window functions, followed by Fourier transformation. For spectra acquired at 25 °C, chemical shifts were referenced to the residual water resonance at 4.76 ppm. The temperature inside the probe at 25 °C and higher temperatures was calibrated with ethylene glycol.

Tryptophan Fluorescence

Samples containing reconstituted alpha A-crystallin were diluted with phosphate buffer (0.1 M Na2SO4, 20 mM NaPi, pH 6.9) to a final concentration of 200 µg/ml and centrifuged for 15 min at 15,000 × g to remove possible light scattering particles. Fluorescence spectra were measured at 25 °C on a Hitachi F-3000 spectrofluorometer equipped with a four-cuvette holder accessory and a thermostated circulating water bath. The excitation wavelength was set to 295 nm with a 5-nm band pass. Fluorescence emission was detected over a range of 300-420 nm with a 3-nm band pass at right angles to the incident beam after passing through a 10-mm quartz cuvette.

Heat Stability Assay

Samples containing reconstituted alpha A-crystallin were diluted with phosphate buffer (0.1 M Na2SO4, 20 mM NaPi, pH 6.9) to a final concentration of 100 µg/ml. Scattering at 360 nm was measured as a function of temperature using a Perkin-Elmer Lambda 2 UV-visible spectrophotometer equipped with a thermostated circulation water bath and a thermocouple to register the sample temperature.

Circular Dichroism Spectroscopy

Circular dichroism (CD) spectra were obtained on a Jasco 720 CD spectropolarimeter. Solutions of alpha A-crystallin at concentrations of 0.25-0.30 mg/ml were prepared in phosphate buffer (0.1 M Na2SO4, 20 mM NaPi, pH 6.9). Experiments were performed over a temperature range from 21 °C to 70 °C using a quartz cell of path length 1 mm. Samples were heated at a rate of 1 °C/min and were left to equilibrate for an empirically determined period of 220 s at each temperature prior to accumulation of data. Spectra acquired at a particular temperature represent an average of four scans.

Miscellaneous Methods

Gel permeation analysis was performed on a Superose 6 HR 10/30 prepacked column as described before (44). High molecular mass standards (Pharmacia Biotech Inc.) were used for calibration. Protein concentrations were determined in triplicate using the Bradford method (51). Binding studies with the hydrophobic probe 8-anilino-1-naphthalenesulfonic acid were performed as described before (52).


RESULTS

Purification and Gel Permeation Analysis

To explore the influence of the C-terminal extension of bovine alpha A-crystallin on chaperone-like activity, we have characterized the structural and functional properties of a number of mutants, which were originally designed to assess the substrate requirements for transglutaminases (53). As shown in Table I, these mutants contain modified C termini in which charged and hydrophobic residues are introduced. Wild-type and mutants were induced in B BL21(DE3)pLysS host cells. Except for the ALWKG mutant, all proteins were predominantly present in the water-soluble fraction of the bacterial lysates. Apparently, the presence of a hydrophobic tryptophan residue in the C-terminal region is unfavorable for the solubility of alpha A-crystallin in the E. coli host cell. The expression products were purified by native and denaturing anion exchange chromatography, resulting in 95-98% pure proteins as estimated by SDS-PAGE (Fig. 1). Additionally, their identity was confirmed by amino acid analysis (data not shown). To avoid isolation and purification artifacts during further analysis, all purified proteins were simultaneously subjected to reconstitution. The refolded proteins were examined for their ability to form multimeric complexes on a Superose 6 gel permeation column. Table I shows that most of the altered C termini do not affect multimerization significantly. The only exception was the ALWKG mutant, where a slightly smaller multimeric mass was observed.

Table I.

The influence of C-terminal mutations in bovine alpha A-crystallin on multimeric mass

Samples of 40 µg of protein in 200 µl of phosphate buffer, pH 6.9, were analyzed on a Superose 6 gel-permeation column. Different preparations of wild-type and mutant alpha A-crystallins were analyzed at least in duplicate. Molecular masses were estimated by calibrating the column with thyroglobulin (669 kDa), ferritin (440 kDa), and catalase (232 kDa).
C-terminal residues of mutant alpha A-crystallinsa Molecular mass

MDa
 170 171 172 173
-Ala-Pro-Ser-Ser-OH (wild-type) 0.64  ± 0.01
-Ala-Pro-Ser-Lys-OH 0.64  ± 0.01
-Ala-Leu-Gly-Lys-Gly-OH 0.65  ± 0.01
-Ala-Leu-Arg-Lys-Gly-OH 0.65  ± 0.01
-Ala-Leu-Asp-Lys-Gly-OH 0.64  ± 0.01
-Ala-Leu-Trp-Lys-Gly-OH 0.61  ± 0.02

a  Wild-type and mutants are referred to in text using amino acid one-letter codes.


Fig. 1. SDS-PAGE of wild-type and mutant alpha A-crystallins. Coomassie Brilliant Blue-stained SDS gel shows the high levels of protein purity (3 µg of protein/lane). Molecular mass markers (M in kDa) are indicated. Samples are as follows: APSS (wild-type) (lane 1), APSK (lane 2), ALGKG (lane 3), ALRKG (lane 4), ALDKG (lane 5), and ALWKG (lane 6).
[View Larger Version of this Image (56K GIF file)]


Chaperone-like Activity

The chaperone-like activity of wild-type and mutants was assessed by determining their ability to prevent the chemically induced aggregation of insulin B-chains at 40 °C. Reduction of the disulfide bonds between the A- and B-chains of insulin with dithiothreitol, rapidly leads to a specific precipitation of aggregated B-chains. As shown in Fig. 2, this event can easily be monitored by measuring the absorbance at 360 nm. Insulin was reduced at different alpha A-crystallin to insulin mass ratios (indicated as percentages). Fig. 2A shows that aggregation of insulin B chains is almost completely prevented in the presence of 100% of wild-type alpha A-crystallin. The APSK, ALGKG, and ALRKG mutants display a small decrease of functional activity (Fig. 2, compare panels B-D with panel A). This decrease is probably caused by the positively charged lysine and arginine residues rather than the uncharged leucine and glycine residues, because there is no substantial difference in activity between the ALGKG and the APSK mutant (Fig. 2, compare panel C with panel B). The ALDKG mutant has the same net charge as the wild-type protein, but the polarity of its extension is obviously increased. However, this has no detectable effect on the ability to bind denaturing substrates (Fig. 2, compare panel E with panel A). On the contrary, a dramatic effect on chaperone-like activity is observed upon introducing a hydrophobic tryptophan residue. As Fig. 2F shows, a considerable level of insulin B aggregation occurs even at an ALWKG mutant to insulin mass ratio of 100%, whereas the wild-type and the other mutants provide almost complete protection at this ratio (Fig. 2, A-E). Thus, unlike charged residues, a strongly hydrophobic residue in the C-terminal extension can seriously disturb functional activity.


Fig. 2. Chaperone-like activity of wild-type and mutant alpha A-crystallins. Reduction-induced aggregation of insulin B is given as a function of time in the absence and presence of various amounts of wild-type (A) and mutant (B-F) alpha A-crystallins. Mutants are designated by their C-terminal sequences. The alpha A to insulin mass ratios in the various experiments are indicated as percentages. Proteins were in a total volume of 1.0 ml phosphate buffer, pH 6.9, and the incubation temperature was 40 °C. The insulin concentration was 245 µg/ml, and the reduction was initiated by addition of 20 µl of 1 M dithiothreitol. All protein concentrations were determined in triplicate using the Bradford assay.
[View Larger Version of this Image (27K GIF file)]


NMR Spectroscopy

The ALDKG and ALWKG mutants were subjected to two-dimensional 1H NMR spectroscopy to determine whether the diminished functional activity of the latter is related to an altered conformation of the C-terminal extension. Fig. 3 shows the cross-peaks arising from alpha -CH resonances in TOCSY spectra at 25 °C of the ALDKG and ALWKG mutants in D2O. The majority of the cross-peaks in the ALDKG spectrum (Fig. 3A) were assigned using the sequential-assignment procedure of Wuthrich (54), which involved the combined use of TOCSY and NOESY spectra in H2O (data not shown). The chemical shifts of the assigned resonances in the ALDKG spectra (TOCSY and NOESY) are very similar to those it shares with wild-type alpha A-crystallin (35) and random coil peptides (55). Therefore, it is clear that this mutant has a flexible C-terminal extension consisting of the last 10 residues (from Glu-165 to Gly-174) and that this extension has little preferred conformation. Comparison of panels A and B (Fig. 3) shows that the ALWKG mutant displays fewer cross-peaks than the ALDKG mutant. For the ALWKG mutant, cross-peaks from the alpha -CH protons were present for the first part of the C-terminal extension (Glu-165 to Ala-170) but not for the remainder (Leu-171 to Lys-173). In the ALDKG mutant, Gly-174 alpha -CH2 does not give rise to cross-peaks in this region of the TOCSY spectrum as these protons are equivalent. It was apparent from the one-dimensional 1H spectra of both mutants, however, that the strong singlet resonance from the alpha -CH2 protons of Gly-174 in the ALDKG mutant (at 3.73 ppm) was absent in the ALWKG mutant (data not shown). No cross-peaks were observed from Lys-166 alpha -CH in the TOCSY spectra of the ALWKG mutant, whereas weak signals were observed in the spectra of wild-type alpha A-crystallin (35) and the ALDKG mutant. This absence could be explained by additional weakness arising from a reduced flexibility due to Lys-166 being at the start of the C-terminal extension and/or the proximity of the Lys-166 alpha -CH resonance to the water resonance resulting in cross-saturation effects. Despite the absence of cross-peaks from the alpha -CH protons of residues in the terminal part of the extension in the ALWKG mutant, resonances were observed from their side chains, e.g. weak cross-peaks were present in the TOCSY spectra between the beta ,gamma -CH and delta -CH3 protons of Leu-171 and from the delta - to epsilon -CH2 protons of Lys-173 and Lys-166. In the one-dimensional 1H NMR spectrum of the ALWKG mutant, broad resonances were also observed at chemical shifts indicative of a tryptophan residue. Presumably, these resonances arise from the solvent-accessible aromatic protons of Trp-172. In the TOCSY spectrum, however, these resonances did not give rise to any cross-peaks, which implies that they have reduced flexibility. In conclusion, the NMR data indicate that the terminal sequence of the C-terminal extension in the ALWKG mutant (Leu-171 to Gly-174) has reduced flexibility compared with the first part of the extension (Glu-165 to Ala-170) and compared with the entire C-terminal extension in the ALDKG mutant.


Fig. 3. 1H NMR spectroscopy of the ALDKG and ALWKG mutants. TOCSY spectra were recorded at 400 MHz and 25 °C. Shown are the alpha -CH resonances of the ALDKG mutant in phosphate buffer in D2O, pH 6.9 (A), and the ALWKG mutant in phosphate buffer in D2O, pH 7.5 (B). Cross-peak assignments based on NOESY sequential analysis are indicated.
[View Larger Version of this Image (24K GIF file)]


Tryptophan Fluorescence Spectroscopy

The ALWKG mutant was subjected to fluorescence spectroscopy to probe the polarity of the micro-environment in which the introduced tryptophan is located. In general, the fluorescence emission maximum of tryptophan residues can vary from about 330 nm (completely buried) to 350 nm (completely exposed) (56). The ALWKG mutant has two tryptophan residues, one at position 9 and the other at position 172 in the C-terminal extension. Both residues contribute to the measured emission spectrum shown in Fig. 4. Since the ALDKG and ALWKG mutants share the Trp-9 in the N-terminal domain, the contribution of the additional Trp-172 in the latter could be determined by calculating the difference between the measured emission spectra. As shown in Fig. 4, the extrapolated spectrum of Trp-172 has a lambda max of 348 nm, indicating that this residue is almost fully exposed to the solvent. Furthermore, the emission intensity of Trp-172 is much lower than that of Trp-9, which also indicates a polar environment because exposed residues display a relatively low quantum yield.


Fig. 4. Tryptophan fluorescence spectroscopy of the ALDKG and ALWKG mutants. Proteins were in a total volume of 1.5 ml of phosphate buffer, pH 6.9, and their concentration of 200 µg/ml was precisely calibrated using the Bradford assay. The excitation wavelength was 295 nm, and the emission spectra were recorded in duplicate using two independent sample preparations. The difference spectrum (Delta ) was calculated by subtracting the ALDKG spectrum from the ALWKG spectrum. The ALDKG spectrum was identical to the APSS wild-type spectrum (data not shown).
[View Larger Version of this Image (20K GIF file)]


Thermostability

To determine whether the thermostability of alpha A-crystallin is conserved upon C-terminal alterations, wild-type and mutants were heated and the absorption at 360 nm was monitored as a function of temperature. As shown in Fig. 5A, the ALWKG mutant, but not the wild-type and the other mutants, rapidly starts to precipitate at 59 °C. To probe further the reduced temperature stability of the ALWKG mutant, the conformation of the ALWKG and ALDKG mutants was investigated as a function of temperature using CD and NMR spectroscopy. Both mutants gave at room temperature a CD spectrum that is typical for alpha -crystallin, i.e. the profiles were characteristic for a high proportion of beta -sheet structure, showing an ellipticity minimum at 218 nm (data not shown). With increasing temperatures above 44 °C, an increase in ellipticity at 205 nm was observed for the ALDKG mutant, such that when the ellipticity was plotted against temperature, a sigmoidal-shaped curve was obtained with a half-point at around 50 °C (Fig. 5B). The increase in ellipticity at 205 nm is indicative of an increase in random coil structure of the protein at these higher temperatures. Similar behavior was observed for native alpha -crystallin, except that the midpoint of this transition was at around 60 °C (57). The CD spectra of the ALWKG mutant were similar to those for the ALDKG mutant over a range from 20 °C to 52 °C (data not shown). However, between 52 °C and 55 °C, the ALWKG mutant precipitated, which was reflected in the uncharacteristic change of ellipticity at 205 nm (Fig. 5B). Nevertheless, the similarities between the CD spectra for both mutants below 52 °C suggest that the ALWKG mutant does not undergo any gross unfolding or unusual conformational changes prior to precipitation.


Fig. 5. Thermostability of wild-type and mutant alpha A-crystallins. A, aggregation of wild-type and mutant alpha A-crystallins as a function of temperature. Proteins were in a total volume of 1.0 ml of phosphate buffer, pH 6.9, and their concentration was 100 µg/ml. The behavior of APSS wild-type and the APSK, ALGKG, and ALRKG mutants was identical to that of the ALDKG mutant (data not shown). B, temperature dependence of ellipticity at 205 nm in CD spectra of the ALDKG and ALWKG mutants. Proteins were in phosphate buffer, pH 6.9, and their concentration was 250-300 µg/ml. Far-UV circular dichroism spectra of the ALDKG and ALWKG mutants were recorded at various temperatures (data not shown), and from the average of four scans the ellipticity at 205 nm was determined.
[View Larger Version of this Image (17K GIF file)]


Temperature-dependent NMR analysis of the ALWKG mutant was consistent with this result. One-dimensional 1H NMR spectra were acquired in 5 °C increments from 25 °C to 55 °C with TOCSY spectra being acquired at 35, 45, and 55 °C. Compared with the spectrum at 25 °C (Fig. 3), there was little change in the NMR spectrum with increasing temperature up to 50 °C. Thus, the same cross-peaks were present and no new cross-peaks were observed, indicating that there was no major unfolding or change in flexibility of the protein at higher temperature. At 55 °C, however, the spectrum became broad and sensitivity was lost due to the sample precipitating out of solution. It would seem, therefore, that increasing temperature up to approximately 55 °C had little effect on the flexibility of the C-terminal extension of the ALWKG mutant or other regions in the molecule.


DISCUSSION

Since it became clear a few years ago that alpha -crystallin is a small heat shock protein with a role in various non-lenticular tissues, there has been great interest in determining the mechanism by which alpha -crystallin interacts in vitro with aggregation-prone proteins. Up to now, it is not known which domains or structural elements of alpha -crystallin subunits are involved in this interaction. In this paper we have focused on structural and functional effects of amino acid replacements in the C-terminal extension of bovine alpha A-crystallin. As shown in Fig. 2, chaperone-like activity is only slightly influenced upon introduction of additional charged residues in this region. In contrast, Fig. 2F demonstrates that insertion of a hydrophobic tryptophan residue decreases the aggregation-suppressing behavior dramatically. To understand this functional behavior at a structural level, the ALWKG mutant was subjected to biophysical examination to explore the structural aspects of its extension. Two-dimensional 1H NMR analysis of the ALDKG and ALWKG mutants showed that substitution of a hydrophilic aspartic acid residue by a hydrophobic tryptophan residue at position 172 leads to a pronounced reduction in flexibility specifically in the vicinity of this residue (Fig. 3). The introduction of tryptophan at position 172 makes the terminal region of the extension relatively hydrophobic in character, i.e. the apolar amino acids Ala-170, Leu-171, Trp-172, and Gly-174 are only offset by the charged Lys-173. Considering this in light of the fact that alpha -crystallin is known to expose a significant hydrophobic surface to solution (37, 39), the reduced flexibility of Ala-170 to Gly-174 is likely to be the result of an extension-domain interaction. This interaction might explain why the multimeric mass of the ALWKG mutant appears to be somewhat lower than that of the wild-type and the other mutants (Table I), i.e. immobilization of the C-terminal extension slightly diminishes the average Stokes' radius of the multimeric particles. Furthermore, the observation that the immobilized tryptophan is still solvent-accessible (Fig. 4) indicates that its binding site is not buried in a domain structure. This result supports the possibility that the hydrophobic extension interacts with substrate binding sites, as these sites are probably located on the surface of the multimeric particles to allow for an efficient aspecific interaction with unfolding proteins.

The immobilization of the terminal part of the ALWKG extension could explain the decreased chaperone-like activity of the mutant in several ways. First of all, as mentioned above it might be possible that binding of the extension reduces the amount of hydrophobic surface available for unfolding substrates. However, this concept is apparently not supported by binding studies with the fluorescent probe 8-anilino-1-naphthalenesulfonic acid, because at 40 °C no significant differences in absolute hydrophobicity were found between wild-type, the ALDKG mutant, and the ALWKG mutant (data not shown). Another possibility is that the immobilized extension diminishes the accessibility of the substrate binding sites by steric hindrance. On the basis of the present data, this hypothesis cannot be excluded, although it does not provide a rationale as to why alpha -crystallin subunits need a flexible C-terminal extension at all. Sequence comparisons show that the extension is quite variable, but so far no mammalian alpha -crystallin subunits have been found lacking such an extension (12, 58). alpha -Crystallin multimers seem to have a defined number of substrate binding sites, which may become occupied by denaturing proteins until a level of saturation is reached (44, 59). This occupation is accompanied by an increase of hydrophobicity because the substrate proteins are bound in a state that is at least partially unfolded (60). Considering this increasing hydrophobicity together with the observation that the extension of wild-type alpha A-crystallin is not affected by substrate binding (60), it might be possible that the extension functions as a sort of solubilizer in the complex. That is to say, the strong hydration of the polar extensions compensates for the relatively high surface hydrophobicity of the complexes formed between alpha A-crystallin and unfolded substrates. Consequently, the poor functional activity of the ALWKG mutant can be explained by the comparatively high tendency of ALWKG-substrate complexes to aggregate because their extensions are immobilized and far less hydrated than those in wild-type alpha A-crystallin and the ALDKG mutant.

The heat-induced precipitation of the ALWKG mutant (Fig. 5A) is a remarkable observation because the wild-type and the other mutants are very thermosoluble. In addition, native alpha -crystallin and mutants of alpha A-crystallin that were analyzed previously, including the elongated alpha Ains-polypeptide, do not precipitate up to at least 75 °C (30, 44, 52). The CD and NMR experiments do not provide any evidence that precipitation of ALWKG mutant at around 55 °C is preceded by precocious unfolding of domain structures. Therefore, this insolubilization probably has a more indirect cause. Although alpha -crystallin does not denature upon heating, at least some of the beta -sheet structure is irreversibly lost in the temperature range between approximately 50 °C and 70 °C (57). In addition, differential scanning calorimetry has revealed a broad endothermic transition for alpha -crystallin at about 60 °C (57, 61). Interestingly, hydrophobic probe binding studies suggest that the apparent thermotropic transition of alpha -crystallin is accompanied by a significant increase in surface hydrophobicity (37, 39). In general, proteins become more hydrophobic with increasing temperature because the water ordering around their apolar surfaces tends to melt out (56). Although this thermodynamic phenomenon may play a role to some extent, it does not explain why the surface hydrophobicity of alpha -crystallin is still increased after a cooling down period (39). Therefore, it is conceivable that the increased surface hydrophobicity is directly correlated to an irreversible structural transition. Fig. 5B shows that the ALDKG and ALWKG mutants display a loss of beta -sheet structure with increasing temperature similar to that for native alpha -crystallin. Furthermore, the precipitation of the ALWKG mutant occurs between 52 and 59 °C, which is in the same range as the thermotropic transition temperature of alpha -crystallin. Because of this, precipitation of the ALWKG mutant may also be related to a structural transition and a concomitant increase in surface hydrophobicity. Basically then, the temperature-induced insolubilization of the ALWKG mutant may have the same cause as its diminished chaperone-like activity, namely that the solubilizing capacity of the immobilized extensions is insufficient to compensate for the increasing hydrophobicity of the domain core of the protein.

Whereas introduction of a tryptophan causes structural changes, i.e. immobilization of the C-terminal extension and a concomitant functional deterioration, insertion of additional charged residues in the C-terminal extension of alpha A-crystallin has only minor effects on the protein's functionality. Perhaps the very presence of a hydrated and flexible extension is more important for solubility and chaperone-like activity than its precise amino acid sequence. The importance of the extension has been noticed before because the C-terminal domain of rat alpha A-crystallin becomes completely insoluble upon removal of the 23 C-terminal residues.2 Furthermore, the observation that the ALWKG mutant is soluble under normal conditions may well be due to the fact that part of its extension, i.e. Glu-165 to Ala-170, is still flexible.

We did not study the effect of hydrophobic residues other than tryptophan. However, it is conceivable that any hydrophobic stretch which restricts the conformational freedom of the C-terminal extension will also affect functional activity. This implies that the polar extension of wild-type alpha A-crystallin has an important physiological function. In fact, the evolutionary conservation of such a polar extension may be dictated by the fact that a non-hydrophobic unstructured C-terminal region is required for increasing the capacity of alpha A-crystallin to form soluble complexes with aggregation-prone polypeptides.


FOOTNOTES

*   This work was supported by the Netherlands Organization for Scientific Research (NWO), National Institutes of Health Grant EY09683 (to W. W. de J.), and the National Health and Medical Research Council of Australia. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
   To whom correspondence should be addressed: Dept. of Biochemistry, University of Nijmegen, P. O. Box 9101, NL-6500 HB Nijmegen, The Netherlands. Tel.: 31-24-3616848/3614254; Fax: 31-24-3540525; E-mail: w.dejong{at}bioch.kun.nl.
1   The abbreviations used are: hsp, heat shock protein(s); TOCSY, total correlation spectroscopy; NOESY, nuclear Overhauser effect spectroscopy; PAGE, polyacrylamide gel electrophoresis.
2   P. R. L. A. van den IJssel and W. W. de Jong, unpublished results.

Acknowledgments

We thank Lennard Horstink and Dr. William Price for useful discussions.


REFERENCES

  1. Groenen, P. J., Merck, K. B., de Jong, W. W., and Bloemendal, H. (1994) Eur. J. Biochem. 225, 1-19 [Medline] [Order article via Infotrieve]
  2. Kato, K., Shinohara, H., Kurobe, N., Goto, S., Inaguma, Y., and Ohshima, K. (1991) Biochim. Biophys. Acta 1080, 173-180 [CrossRef][Medline] [Order article via Infotrieve]
  3. Srinivasan, A. N., Nagineni, C. N., and Bhat, S. P. (1992) J. Biol. Chem. 267, 23337-23341 [Abstract/Free Full Text]
  4. Deretic, D., Aebersold, R. H., Morrison, H. D., and Papermaster, D. S. (1994) J. Biol. Chem. 269, 16853-16861 [Abstract/Free Full Text]
  5. Bhat, S. P., and Nagineni, C. N. (1989) Biochem. Biophys. Res. Commun. 158, 319-325 [CrossRef][Medline] [Order article via Infotrieve]
  6. van Noort, J. M., van Sechel, A. C., Bajramovic, J. J., Elouagmiri, M., Polman, C. H., Lassmann, H., and Ravid, R. (1995) Nature 375, 798-801 [CrossRef][Medline] [Order article via Infotrieve]
  7. Iwaki, T., Kume Iwaki, A., Liem, R. K., and Goldman, J. E. (1989) Cell 57, 71-78 [CrossRef][Medline] [Order article via Infotrieve]
  8. Iwaki, T., Iwaki, A., Tateishi, J., Sakaki, Y., and Goldman, J. E. (1993) Am. J. Pathol. 143, 487-495 [Abstract]
  9. Lowe, J., McDermott, H., Pike, I., Spendlove, I., Landon, M., and Mayer, R. J. (1992) J. Pathol. 166, 61-68 [CrossRef][Medline] [Order article via Infotrieve]
  10. Renkawek, K., Voorter, C. E., Bosman, G. J., van Workum, F. P., and de Jong, W. W. (1994) Acta Neuropathol. Berl. 87, 155-160 [Medline] [Order article via Infotrieve]
  11. Ingolia, T. D., and Craig, E. A. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 2360-2364 [Abstract/Free Full Text]
  12. Caspers, G-J., Leunissen, J. A. M., and de Jong, W. W. (1995) J. Mol. Evol. 40, 238-248 [CrossRef][Medline] [Order article via Infotrieve]
  13. Klemenz, R., Frohli, E., Steiger, R. H., Schafer, R., and Aoyama, A. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 3652-3656 [Abstract/Free Full Text]
  14. van den IJssel, P. R., Overkamp, P., Knauf, U., Gaestel, M., and de Jong, W. W. (1994) FEBS Lett. 355, 54-56 [CrossRef][Medline] [Order article via Infotrieve]
  15. Chiesi, M., Longoni, S., and Limbruno, U. (1990) Mol. Cell Biochem. 97, 129-136 [Medline] [Order article via Infotrieve]
  16. Miron, T., Vancompernolle, K., Vandekerckhove, J., Wilchek, M., and Geiger, B. (1991) J. Cell. Biol. 114, 255-261 [Abstract/Free Full Text]
  17. Voorter, C. E., Mulders, J. W., Bloemendal, H., and de Jong, W. W. (1986) Eur. J. Biochem. 160, 203-210 [Medline] [Order article via Infotrieve]
  18. Stokoe, D., Engel, K., Campbell, D. G., Cohen, P., and Gaestel, M. (1992) FEBS Lett. 313, 307-313 [CrossRef][Medline] [Order article via Infotrieve]
  19. Voorter, C. E., Wintjes, L., Bloemendal, H., and de Jong, W. W. (1992) FEBS Lett. 309, 111-114 [CrossRef][Medline] [Order article via Infotrieve]
  20. Arrigo, A.-P., Suhan, J. P., and Welch, W. J. (1988) Mol. Cell. Biol. 8, 5059-5071 [Abstract/Free Full Text]
  21. Horwitz, J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 10449-10453 [Abstract/Free Full Text]
  22. Jakob, U., Gaestel, M., Engel, K., and Buchner, J. (1993) J. Biol. Chem. 268, 1517-1520 [Abstract/Free Full Text]
  23. Merck, K. B., Groenen, P. J. T. A., Voorter, C. E. M., de Haard-Hoekman, W. A., Horwitz, J., Bloemendal, H., and de Jong, W. W. (1993) J. Biol. Chem. 268, 1046-1052 [Abstract/Free Full Text]
  24. Carver, J. A., Aquilina, J. A., and Truscott, R. J. W. (1994) Exp. Eye Res. 59, 231-234 [CrossRef][Medline] [Order article via Infotrieve]
  25. Singh, K., Groth-Vasselli, B., Kumosinski, T. F., and Farnsworth, P. N. (1995) FEBS Lett. 372, 283-287 [CrossRef][Medline] [Order article via Infotrieve]
  26. Bindels, J. G., Siezen, R. J., and Hoenders, H. J. (1979) Ophthalmic Res. 11, 711-724
  27. Tardieu, A., Laporte, D., Licinio, P., Krop, B., and Delaye, M. (1986) J. Mol. Biol. 192, 711-724 [CrossRef][Medline] [Order article via Infotrieve]
  28. Wistow, G. (1993) Exp. Eye Res. 56, 729-732 [CrossRef][Medline] [Order article via Infotrieve]
  29. Siezen, R. J., and Argos, P. (1983) Biochim. Biophys. Acta 748, 56-67 [CrossRef][Medline] [Order article via Infotrieve]
  30. Maiti, M., Kono, M., and Chakrabarti, B. (1988) FEBS Lett. 236, 109-114 [CrossRef][Medline] [Order article via Infotrieve]
  31. Wistow, G. (1985) FEBS Lett. 181, 1-6 [CrossRef][Medline] [Order article via Infotrieve]
  32. van den Oetelaar, P. J., and Hoenders, H. J. (1989) Biochim. Biophys. Acta 995, 91-96 [CrossRef][Medline] [Order article via Infotrieve]
  33. Merck, K. B., de Haard-Hoekman, W. A., Oude Essink, B. B., Bloemendal, H., and de Jong, W. W. (1992) Biochim. Biophys. Acta 1130, 267-276 [Medline] [Order article via Infotrieve]
  34. Carver, J. A., Aquilina, J. A., and Truscott, R. J. (1993) Biochim. Biophys. Acta 1164, 22-28 [CrossRef][Medline] [Order article via Infotrieve]
  35. Carver, J. A., Aquilina, J. A., Truscott, R. J., and Ralston, G. B. (1992) FEBS Lett. 311, 143-149 [CrossRef][Medline] [Order article via Infotrieve]
  36. Carver, J. A., Esposito, G., Schwedersky, G., and Gaestel, M. (1995) FEBS Lett. 369, 305-310 [CrossRef][Medline] [Order article via Infotrieve]
  37. Raman, B., and Rao, Ch. M. (1994) J. Biol. Chem. 269, 27264-27268 [Abstract/Free Full Text]
  38. Raman, B., Ramakrishna, T., and Rao, C. M. (1995) FEBS Lett. 365, 133-136 [CrossRef][Medline] [Order article via Infotrieve]
  39. Das, K. P., and Surewicz, W. K. (1995) FEBS Lett. 369, 321-325 [CrossRef][Medline] [Order article via Infotrieve]
  40. Kelley, M. J., David, L. L., Iwasaki, N., Wright, J., and Shearer, T. R. (1993) J. Biol. Chem. 268, 18844-18849 [Abstract/Free Full Text]
  41. Takemoto, L. (1992) Exp. Eye Res. 59, 239-242
  42. de Jong, W. W., Lubsen, N. H., and Kraft, H. J. (1994) Prog. Retinal Eye Res. 13, 391-442 [CrossRef]
  43. Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W. (1989) Methods Enzymol. 185, 60-89
  44. Smulders, R. H. P. H., van Geel, I. G., Gerards, W. L. H., Bloemendal, H., and de Jong, W. W. (1995) J. Biol. Chem. 270, 13916-13924 [Abstract/Free Full Text]
  45. Farahbakhsh, Z. T., Huang, Q. L., Ding, L. L., Altenbach, C., Steinhoff, H. J., Horwitz, J., and Hubbell, W. L. (1995) Biochemistry 34, 509-516 [CrossRef][Medline] [Order article via Infotrieve]
  46. Marion, D., and Wuthrich, K. (1983) Biochem. Biophys. Res. Commun. 113, 967-974 [CrossRef][Medline] [Order article via Infotrieve]
  47. Griesinger, C., Otting, G., Wuthrich, K., and Ernst, R. R. (1988) J. Am. Chem. Soc. 110, 7870-7872 [CrossRef]
  48. Bax, A., and Davis, D. G. (1985) J. Magn. Reson. 65, 355-360
  49. Jeener, J., Meier, B. H., Bachmann, P., and Ernst, R. R. (1979) J. Chem. Phys. 48, 286-292
  50. Piotto, M., Saudek, V., and Sklenar, V. (1992) J. Biomol. NMR 2, 661-665 [CrossRef][Medline] [Order article via Infotrieve]
  51. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]
  52. Smulders, R. H. P. H., Merck, K. B., Aendekerk, J., Horwitz, J., Takemoto, L., Slingsby, C., Bloemendal, H., and de Jong, W. W. (1995) Eur. J. Biochem. 232, 834-838 [Medline] [Order article via Infotrieve]
  53. Grootjans, J. J., Groenen, P. J. T. A., and de Jong, W. W. (1995) J. Biol. Chem. 270, 22855-22858 [Abstract/Free Full Text]
  54. Wuthrich, K. (1986) NMR of Proteins and Nucleic Acids, John Wiley & Sons, New York
  55. Lebreton, E. R., and Carver, J. A. (1996) Int. J. Pept. Protein Res. 47, 9-19 [Medline] [Order article via Infotrieve]
  56. Creighton, T. E. (1993) Proteins: Structures and Molecular Properties, p. 270, W. H. Freeman, New York
  57. Surewicz, W. K., and Olesen, P. R. (1995) Biochemistry 34, 9655-9660 [CrossRef][Medline] [Order article via Infotrieve]
  58. Hendriks, W., Sanders, J., de Leij, L., Ramaekers, F., Bloemendal, H., and de Jong, W. W. (1988) Eur. J. Biochem. 174, 133-137 [Medline] [Order article via Infotrieve]
  59. Wang, K., and Spector, A. (1994) J. Biol. Chem. 269, 13601-13608 [Abstract/Free Full Text]
  60. Carver, J. A., Guerreiro, N., Nicholls, K. A., and Truscott, R. J. W. (1995) Biochim. Biophys. Acta 1252, 251-260 [CrossRef][Medline] [Order article via Infotrieve]
  61. Walsh, M. T., Sen, A. C., and Chakrabarti, B. (1991) J. Biol. Chem. 266, 20079-20084 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J BiochemHome page
A. Biswas, S. Lewis, B. Wang, M. Miyagi, P. Santoshkumar, M. H. Gangadhariah, and R. H. Nagaraj
Chemical Modulation of the Chaperone Function of Human {alpha}A-Crystallin
J. Biochem., July 1, 2008; 144(1): 21 - 32.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
A. Saha, A. Sharma, A. Dhar, B. Bhattacharyya, S. Roy, and S. K. Das Gupta
Antagonists of Hsp16.3, a Low-Molecular-Weight Mycobacterial Chaperone and Virulence Factor, Derived from Phage-Displayed Peptide Libraries
Appl. Envir. Microbiol., November 1, 2005; 71(11): 7334 - 7344.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Bhattacharyya, S. Ray, S. Bhattacharya, and A. Chakrabarti
Chaperone Activity and Prodan Binding at the Self-associating Domain of Erythroid Spectrin
J. Biol. Chem., December 31, 2004; 279(53): 55080 - 55088.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Gupta and O. P. Srivastava
Deamidation Affects Structural and Functional Properties of Human {alpha}A-Crystallin and Its Oligomerization with {alpha}B-Crystallin
J. Biol. Chem., October 22, 2004; 279(43): 44258 - 44269.
[Abstract] [Full Text] [PDF]